Levosimendan for hemodynamic support after cardiac surgery

Left ventricular dysfunction following cardiac surgery remains a significant perioperative challenge, one often treated with inotropic support, however practice patterns vary widely and there are few outcome data to support a standardised practice. Levosimendan represents a newer class of ‘inodilators’, calcium sensitizers, thought to improve cardiac output without increasing myocardial oxygen consumption. In the Levosimendan to Reduce …